Análisis e interpret Ación De los result ADos De l As ev Alu Aciones económic As. r egl As De Decisión

Jorge-Eduardo Martínez Pérez, José Luis Pinto Prades, Estimación del valor monetario de los años de vida ajustados por calidad: estimaciones preliminares Ekonomiaz: Revista vasca de economía. ,vol. 60, pp. 192- 209 ,(2005)

Lambert A. Wu, Thomas E. Kottke, Number needed to treat: caveat emptor. Journal of Clinical Epidemiology. ,vol. 54, pp. 111- 116 ,(2001) , 10.1016/S0895-4356(00)00278-X

Javier Soto Álvarez, Cálculo de la eficiencia de oportunidad de los nuevos medicamentos PharmacoEconomics Spanish Research Articles. ,vol. 3, pp. 3- 5 ,(2006) , 10.1007/BF03320905

Andrew Briggs, Alastair Gray, Using cost effectiveness information. BMJ. ,vol. 320, pp. 246- 246 ,(2000) , 10.1136/BMJ.320.7229.246

A. Laupacis, D. Feeny, P. X. Tugwell, A. S. Detsky, How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations Canadian Medical Association Journal. ,vol. 146, pp. 473- 481 ,(1992)

John F.P. Bridges, Eberechukwu Onukwugha, C. Daniel Mullins, Healthcare Rationing by Proxy PharmacoEconomics. ,vol. 28, pp. 175- 184 ,(2010) , 10.2165/11530650-000000000-00000

John Appleby, Nancy Devlin, David Parkin, Martin Buxton, Kalipso Chalkidou, Searching for cost effectiveness thresholds in the NHS Health Policy. ,vol. 91, pp. 239- 245 ,(2009) , 10.1016/J.HEALTHPOL.2008.12.010

Ivar Sønbø Kristiansen, Dorte Gyrd-Hansen, Cost-effectiveness analysis based on the number-needed-to-treat: common sense or non-sense? Health Economics. ,vol. 13, pp. 9- 19 ,(2004) , 10.1002/HEC.797

F. A. McAlister, The “number needed to treat” turns 20 — and continues to be used and misused Canadian Medical Association Journal. ,vol. 179, pp. 549- 553 ,(2008) , 10.1503/CMAJ.080484

Stuart J Peacock, Craig Mitton, Danny Ruta, Cam Donaldson, Angela Bate, Lindsay Hedden, Priority setting in healthcare: towards guidelines for the program budgeting and marginal analysis framework Expert Review of Pharmacoeconomics & Outcomes Research. ,vol. 10, pp. 539- 552 ,(2010) , 10.1586/ERP.10.66